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Abstract  
Translocation of cell-penetrating peptides is often promoted by increased content of 
arginine or other guanidinum groups. However, relatively little research has considered 
the role of these functional groups on antimicrobial peptide activity. This study compared 
the activity of three histone-derived antimicrobial peptides—buforin II, DesHDAP1, and 
parasin— with variants that contain only lysine or arginine cationic residues. These 
peptides operate via different mechanisms as parasin causes membrane permeabilization 
while buforin II and DesHDAP1 translocate into bacteria. For all peptides, antibacterial 
activity increased with increased arginine content. Higher arginine content increased 
permeabilization for parasin while it improved translocation for buforin II and 
DesHDAP1. These observations provide insight into the relative importance of arginine 




AMP:  antimicrobial peptide; BF2:  buforin II; CD:  circular dichroism; CPP:  cell-
penetrating peptide; HDAP:  histone-derived antimicrobial peptide 	   	  
1. Introduction 
 
Bacterial resistance to antimicrobial drugs has become stronger, but there have been few 
recent advances in antimicrobials that combat this resistance.1-5 Antimicrobial peptides 
(AMPs) are effective antibacterial agents, which also can have antiviral, antifungal and 
antitumor activities.1, 2 Many antimicrobial peptides use a lytic mechanism, disrupting the 
bacterial membrane.2-6 However, other AMPs act by translocating through the membrane 
and affecting intracellular processes.7-10 These translocating antimicrobial peptides may 
be particularly apt to avoid antimicrobial resistance.3-5  
 
In nature, antimicrobial peptides are often cationic. Because cationic residues attract the 
peptide to the anionic bacterial membrane, changing the arginine or lysine content can 
affect the antimicrobial activity. Despite their identical charge, arginine residues are more 
prevalent in naturally occurring antimicrobial peptides than lysine, implying that the 
guanidinium group in arginine may be preferable for activity than the amine group found 
in lysine.6, 11 Based on the observed prevalence of arginine residues, a few researchers 
have attempted to enhance antimicrobial activity of peptides and synthetic peptoids by 
increasing the relative composition of arginine residues or guanidinium moieties. In many 
studies, increased arginine/guanidinium vs. lysine/amine composition seems to enhance 
activity,12-18 although this trend is not universally observed.12, 19-22 The fact that several 
studies have noted the importance of guanidinium groups in promoting the translocation 
of cell-penetrating peptides (CPPs),14, 15, 23-25 supports the importance of 
arginine/guanidinium composition for AMPs with a translocation-based mechanism.  
There is less evidence supporting the importance of these groups in the activity of AMPs 
with a membrane permeabilizing mechanism, although recent results have shown 
increased activity of defensin variants containing increased arginine composition.18  
 
This study systematically considers the role of arginine composition on three histone-
derived peptides (HDAPs), buforin II, DesHDAP1 and parasin (Table 1), by observing 
how mutating their cationic residues to all arginine or all lysine affects their antibacterial 
activity and mechanism. Histones and many of their fragments have been shown to have 
antibacterial properties.8, 9, 26 BF2, a naturally occurring peptide, and DesHDAP1, a 
designed peptide, have been shown to kill microbes by crossing the bacterial membrane 
and interacting with DNA without significant membrane permeabilization.8-10, 27-29 
Conversely, the naturally occurring peptide parasin kills cells through a lytic 
mechanism.30 Our results show that increasing the arginine composition of these peptides 
enhances their activity regardless of their mechanism. These results provide support for 
the general strategy of enhancing the membrane activity of AMPs through increased 
arginine content.   
 
 
2. Materials and Methods  
2.1 Materials 
All peptides used in this study were synthesized by NeoBioSci (Cambridge, MA) and 
obtained at >95% purity. BF2 and parasin contained F10W and A14W mutations, 
respectively, for peptide membrane insertion and translocation studies. POPC, POPE and 
DNS-PE lipids were obtained from Avanti Polar Lipids (Alabaster, AL) and other 
chemicals were obtained from Sigma unless otherwise noted.  
 
2.2 Circular dichroism spectroscopy  
Circular dichroism (CD) spectra of each peptide were collected on an Olis DSM 1000 
(Bogart, GA) using a 1-mm path-length quartz cell. Peptides were 25 µM solutions in 1:1 
TFE:phosphate buffer (10 mM sodium phosphate, 45 mM NaCl, 1 mM EDTA, pH 7.4), a 
solution previously shown to mimic membrane environments for these peptide 
structures.9, 31 For each sample, three scans from 250 to 195 nm with 60 s integration at 
each wavelength were averaged at 37 °C. 
 
2.3 Bacterial preparation  
For radial diffusion and propidium iodide assays, 50 mL of Tryptic Soy Broth (TSB) was 
inoculated with 50 µL of overnight E. coli bacterial culture in TSB and incubated for 3 
hours at 37 °C while shaking. The culture was then centrifuged at 4 °C for 10 minutes at 
880xg and resuspended in 10 mM sodium phosphate buffer (pH 7.4). This sample was 
pelleted under the same conditions and resuspended again. Data is presented for E. coli 
strain Carolina #25922, although analogous trends also were observed for Top10 E. coli 
(Invitrogen). 
 
2.4 Radial diffusion assay  
Radial diffusion assays were based on the protocols presented previously.32, 33 10 mL of 
melted underlay (1% TSB, 1% agarose w/v, 10 mM sodium phosphate, pH 7.4) was 
vortexed with 4x106 CFU of bacteria resuspended in phosphate buffer and poured into a 
petri dish. Wells were made using a pipette attached to a bleach trap, and each well was 
filled with 2.0 µL of 3x10−4 M of peptide solution or water. After a three hour incubation 
at 37 °C, the plates were covered with 10 mL of overlay agar (6% w/v TSB, 1% w/v 
agarose) and incubated overnight at 37 °C. Following incubation, the diameter of 
bacterial clearance was measured. Measurements were taken for at least three separate 
overnight cultures for each peptide, each with multiple wells.  
 
2.5 Peptide membrane insertion  
To form vesicles, lipids dissolved in chloroform at a 75:25 ratio of POPC:POPG were 
dried and reconstituted in a 1:1 mixture by volume of HEPES buffer (10 mM HEPES, 45 
mM NaCl, 1 mM EDTA, pH 7.4). The lipids were subjected to five freeze-thaw cycles in 
liquid nitrogen and then were extruded twenty-one times through a Whatman 0.1µm 
Nucleopore filter (Whatman) at 25°C using an extruder (Avanti Polar Lipids). The 
sample was then returned to its original volume in 10 mM HEPES buffer. The 
concentration of vesicles was determined using a phosphorous assay.34 
 
Three solutions were then prepared for titration with lipid: two containing 5x10-6 M of 
peptide in 10 mM HEPES buffer and one containing 0.015 mL tryptophan in HEPES 
buffer.  Vesicles were added to one of the peptide solutions and the tryptophan solution 
and allowed to incubate for 5 minutes before taking a fluorescence emission spectrum 
from 300-450 nm of all three samples with an excitation of 280 nm.  Vesicle additions 
were continued until peptide samples showed no additional blue shift. Each spectrum was 
collected as the average of 10 scans using a Varian Cary Eclipse fluorescence 
spectrophotometer.   
 
The fluorescence emission for the peptide titrated with vesicles was then adjusted at each 
collected wavelength using the control peptide solution without added lipid and the 
tryptophan solution with added vesicles (Equation 1). The peptide alone corrects for any 
loss of fluorescence due to adsorption to the glass cuvette, as observed previously for 
BF2,35 while the tryptophan solution corrects for light scattering caused by vesicles.36 For 
each addition of lipid, the peak of the adjusted peptide fluorescence was measured by 
fitting the symmetric portion of the spectra data to a Gaussian curve using KaliedaGraph 
(Synergy Software).  Peak wavelengths reported for each peptide were averaged over 
three titrations performed with at least two independently produced vesicle samples.  
 
Equation 1.  
adjusted fluorescence = F!"#!$%&!'()* ∗ F!"#$%&$!!"F!"#$%&$'(),!"#$%  !"#$%&'   ∗    F!"#$%"&    F!"#$%"&,!"#$%  !"#$%&'   
 
2.6 Propidium iodide (PI) uptake assay  
The PI uptake assay was used to determine the relative membrane permeabilization 
caused by each peptide. The change in fluorescence intensity of PI (1 mg/mL) mixed 
with 3.75×108 CFU E. coli culture in 10 mM phosphate buffer upon addition of 2×10-6 M 
peptide was measured using a Varian Cary Eclipse fluorescence spectrophotometer with 
excitation and emission of 535 nm and 617 nm, respectively. The permeabilizing ability 
of each peptide was calculated as the relative fluorescence increase due to propidium 
iodide•DNA binding five minutes after the addition of peptide to bacteria (Equation 2).  
Each peptide was tested using bacteria from at least two different overnight cultures. 
 
Equation 2. 
relative  permeability = F!  !"#  after  peptide  additionF!  !"#  after  peptide  addition 
 
2.7 Translocation assay 
The translocation assay was performed analogous manner to previous HDAP studies.27, 
37-39 To form experimental vesicles, lipids dissolved in chloroform at a 75:20:5 ratio of 
POPC:POPG:DNS-PE were dried and reconsituted in a 1:1 volume mixture by volume of 
10 mM HEPES buffer and 0.4 mM trypsin in 10 mM HEPES buffer solution for a final 
concentration of 0.2 mM trypsin. For control vesicles, Bowman-Birk Inhibitor was added 
to the reconstitution mixture for a final concentration of 2.0 mM. Extrusion and 
quantification was performed as described above for membrane insertion studies. 
Samples of control vesicles used for quantification were centrifuged for 10 minutes at 
14,000 x g in Nanosep 10K centrifugal devices with omega membrane (Pall Corporation) 
to remove phosphorous salts.   
 
For both control and experimental samples in the assay, 200 µL samples of 0.250 mM 
vesicles in 10 mM HEPES buffer were placed in a microcentrifuge vial.  For 
experimental vesicles, the 200 µL sample also included 4.0 mM Bowman Birk inhibitor. 
Vesicle solutions were heated to 37 °C, gently vortexed and added to the wells of a 96 
well plate containing 3x10-6 M peptide. Fluorescence measurements were begun 
immediately and measured for 25 minutes on a Spectra Max M3 plate reader with 
excitation and emission of 280 nm and 525 nm, respectively. 
 
Translocation was quantitated by dividing the average control relative fluorescence in the 
last minute by the average experimental relative fluorescence in the last minute (Equation 
3), with relative fluorescence equaling the FRET divided by the FRET at t=0.  Thus, a 
translocation ratio of 1 would imply no translocation, and ratios greater than one would 
indicate translocation. Translocation was only calculated for trials when the relative 
control fluorescence did not drop below 0.85, since in an ideal trial all of the vesicle-
encapsulated trypsin would be inhibited, giving a relative control fluorescence of 1.  The 
translocation of each peptide was averaged over at least three trials using at least two 
independently prepared sets of vesicle solutions.  
 
Equation 3.    
 
Translocation  ratio =    (average  FRET  of  control  vesicles)!"!!"#$% (FRET  of  control  vesicles)!"#$  (average  FRET  of  exp. vesicles)!"!!"#$% (FRET  of  exp. vesicles)!"#$  
 
  
3. Results and Discussion 
3.1 Changing cationic residues between arginine and lysine does not significantly affect 
peptide structure 
The secondary structures of the native HDAPs were compared to their lysine and arginine 
mutants using circular dichroism (CD) spectroscopy in 1:1 TFE:phosphate solutions to 
provide a membrane-mimetic environment.27 CD spectra of the wild type peptides 
correspond with previous measurements (Fig. 1).27, 28, 30, 35 The spectra of both BF2 and 
DesHDAP1 are consistent with a partially helical structure. Parasin similarly shows a 
mixed structure with somewhat increased α-helical character relative to the other 
peptides. Changing the identity of the basic residues had no appreciable change in the 
secondary structure of the mutants in comparison to the wildtype peptides (Fig. 1).   
 
3.2 Increasing arginine composition of peptides increases antimicrobial activity  
The antimicrobial activity of BF2, DesHDAP1, parasin and their mutants against E. coli 
was measured using a radial diffusion assay (Fig. 2), where an increased diameter of 
bacterial clearance indicated increased antimicrobial activity. For all three peptides, 
arginine mutants had significantly increased antimicrobial activity compared to the lysine 
mutants. The region of bacterial clearance was only partial for both parasin and parasinK, 
with an inner fully cleared circle surrounded by a dense ring of bacteria and a larger outer 
ring of partially cleared (less dense) E. coli. A similar observation was made for parasin 
in previous studies.31 ParasinR, on the other hand, completely cleared the radius, 
consistent with its increased activity.  
 Interestingly, a correlation between α-helical structure and activity does not emerge in 
this study as enhanced activity of arginine mutants (Fig. 2) is not accompanied by notably 
different structures in our CD data (Fig. 1). In the case of BF2 and DesHDAP1, this may 
be related to the presence of a helix breaking proline residue in the middle of the peptide. 
Previous results have shown the importance of these proline residues for BF2 and 
DesHDAP1 activity,9, 10, 27, 37 and computer simulations have implied that the membrane 
entry of BF2 is enhanced by its ability to deform its N-terminal structure.40 Future studies 
could consider whether deformation may play a similar role in DesHDAP1 and parasin.  
 
3.3 Increased arginine content enhances peptide embedding into membranes 
In order to explain the increased antimicrobial activity of peptides containing arginine 
instead of lysine, we considered the ability of our peptides to embed into lipid 
membranes by monitoring their blue shift in the presence of vesicles. For these 
experiments, we titrated peptides with 3:1 POPC:POPG vesicles until obtaining a 
maximum blue shift, shown in Table 2. Of the three peptides, only DesHDAP1 showed a 
statistically significant trend in comparing arginine and lysine mutants, and the shift for 
these peptides was relatively small albeit consistent with somewhat increased membrane 
embedding. No discernable effect was observed for parasin mutants, and any potential 
trend between BF2 arginine and lysine mutants was too small to reliably interpret. While 
quantitatively small, these observations led us to further consider whether arginine/lysine 
mutants altered other membrane-related mechanistic properties in these three peptides. 
 3.4 Changes in antimicrobial mechanism with lysine and arginine mutations 
3.4.1 Arginine promotes membrane permeabilization more than lysine  
To analyze one potential mechanism of bacterial death based on membrane interactions, 
the ability of the HDAPs and their mutants to permeabilize the bacterial membrane of E. 
coli was determined using a PI uptake assay (Fig. 3). In this assay, increased membrane 
permeabilization allows PI to bind intracellular DNA, giving an increased fluorescence. 
For all three peptides, arginine mutants caused significantly greater membrane 
permeabilization than lysine mutants. This was particularly notable in parasin, which 
primarily functions through causing membrane permeabilization.30 However, even 
though wild type BF2 and DesHDAP1 cause relatively low levels of permeabilization 
compared to a prototypical lytic peptide, such as magainin, their lysine mutations still 
showed significantly decreased permeabilization similar to that of two non-
permeabilizing peptides considered in previous work (HipC and DesHDAP3).37, 39 
Relatively smaller changes in permeabilization for the arginine mutations in BF2 and 
DesHDAP1 compared to wild type may be attributed to a difference of only one (BF2) or 
two (DesHDAP1) residues in those mutants versus wildtype. 
 
3.4.2 Arginine improves membrane translocation relative to lysine 
To analyze the translocation ability of BF2, DesHDAP1 and their mutants, vesicles made 
of 70:25:5 POPC:POPG:DNS-POPE encapsulated with trypsin were mixed with peptide 
to determine whether peptide crosses the membrane and becomes proteolyzed. In this 
assay, increased translocation causes peptide cleavage by the encapsulated trypsin, 
leading to a decreased FRET signal. This FRET signal is compared to the FRET for the 
same peptide with a control sample of vesicles in which the encapsulated trypsin is 
inhibited to ensure decreased fluorescence is due to membrane translocation. Parasin and 
its mutants were not amenable to this assay because they induce relatively high 
membrane permeabilization, and the assay relies on membrane integrity to maintain 
trypsin on the inside of vesicles for reliable results. Data for peptides previously observed 
to show a low level (HipC) and essentially no (DesHDAP3) translocation in lipid vesicle 
assays and cellular microscopy experiments were shown for comparison (Fig. 4).37, 39 
 
The BF2K and DesHDAP1K mutants caused a clear decrease in translocation compared 
to their arginine counterparts (Fig. 4). These peptides show translocation very similar to 
that of an entirely non-translocating peptide (DeHDAP3), consistent with their decreased 
antibacterial activity. As seen for permeabilization, the slight increases in translocation 
for BF2R and DesHDAP1R were not necessarily significant, again potentially stemming 
from the more conservative nature of these mutations. 
 
4. Conclusions  
In this study, we considered the effect of arginine and lysine content on the antimicrobial 
activity and membrane properties of three HDAPs with differing mechanisms of action. 
Increasing the composition of arginine versus lysine residues improved antibacterial 
activity for these peptides. For parasin, a lytic peptide, this increase seems to result from 
increased membrane permeabilization. This observation highlights the potential for 
altered arginine content to enhance the activity of membrane permeabilizing AMPs.  For 
BF2 and DesHDAP1, which rely on translocating into the cell as their main antimicrobial 
mechanism, the presence of arginine residues seems to promote translocation as shown 
by the dramatic loss of translocation in BF2K and Des1K in comparison to that of the 
wildtype. In addition, there was some effect on membrane permeabilization as arginine 
content increased BF2 and DesHDAP1. This leaves open the possibility that the altered 
antimicrobial activity in the BF2 and DesHDAP1 arginine mutants is not solely based on 
the increase in translocation. Interestingly, the comparable relative translocation and 
permeabilization of wild type BF2 and BF2R could not explain the increased 
antimicrobial activity observed for BF2R. Instead, the increased activity may have 
resulted from altered binding to its intracellular target. Possible changes in nucleic acid 
binding for these peptides is the focus on ongoing work in our lab.  
 
The results presented here are consistent with the importance of arginine residues in the 
activity of AMPs and provide further evidence for considering increased arginine or 
guanidinium content in the design of antimicrobial peptides and peptoids. Recent work 
by Wong and co-workers has implied that the ability of arginine sidechains to form 
bidentate interactions with lipids can lead to enhanced Gaussian, or “saddle-splay,” 
membrane curvature, while lysine residues that only form monodentate interactions do 
not readily induce this curvature on their own.18, 41, 42  The ability to induce increased 
curvature can enhance the activity of both translocating and membrane permeabilizing 
peptides.  
 
As well, our observations are interesting in light of other recent work more broadly 
considering the role of arginine residues in membrane proteins.  For example, Moon and 
Fleming found that arginine residues were more energetically favorable than lysine in the 
transmembrane regions of OmpLA.43 They also observed that there may be some 
cooperativity for placing multiple arginine residues into the membrane. These finding 
appear consistent with the increased membrane effects of arginine mutants in this study, 
although our systems are very different in nature.  In another well-characterized system, 
mutating the twin-arginine motif of Tat signal peptides to a twin-lysine typically removes 
their ability to interact with the Tat translocation machinery.44-46  Although Tat systems 
involve a distinct mechanism of translocation from the peptides considered in this study, 
these results further emphasize the different role of arginine and lysine residues in 
membrane protein function.  Other studies have compared the structural stability of 
arginine versus lysine in a four-helix bundle47 and have considered the role of arginine 
residues in the transmembrane regions of ion channels.48, 49 Together with the results 
presented here, these studies increasingly highlight the important role that arginine can 
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Figure 1: Circular dichroism spectra of 25 µM wildtype and mutant variants of (a) BF2, 
(b) DesHDAP1 and (c) parasin in 1:1 TFE:phosphate buffer. 
 
Figure 2:  Radius of clearance observed for E. coli in radial diffusion assays with 
histone-derived peptides (gray) and their arginine (black) and lysine (white) mutants.  
The average region of clearance noted for parasin and its mutants for E. coli are reported 
as the inner radial clearance that contained no bacteria.  ** denotes p≤0.001 for 
comparisons between arginine and lysine mutants of a peptide.  Uncertainty shown as 
standard error.  
 
Figure 3:  (a-c) Representative traces of relative fluorescence increases (F/F0) over time 
for (a) BF2, (b) DesHDAP1 and (c) parasin wild type (gray circle), arginine (black circle) 
and lysine (white circle) variants.  Data for magainin (black diamond), HipC (white 
diamond) and DesHDAP3 (gray diamond) from 37, 39 provided for comparison.  (d) 
Relative fluorescence increase of propidium iodide five minutes after the addition of 
histone-derived peptides (gray) and their arginine (black) and lysine (white) mutants to E. 
coli cells.  Data for wild type magainin, HipC and DesHDAP3 from 37, 39 provided for 
comparison.  * denotes p≤0.01 for comparisons between arginine and lysine mutants of a 
peptide.  Uncertainty shown as standard error.  
Figure 4:  Translocation ratios (defined in equation 3) for histone-derived peptides (gray) 
and their arginine (black) and lysine (white) mutants into lipid vesicles.  An increased 
ratio implies increased translocation across cell membranes.  Data for HipC and 
DesHDAP3 from 37, 39 provided for comparison.  * denotes p≤0.01 and ** denotes 
p≤0.001 for  comparisons between arginine and lysine mutants of a peptide.  Uncertainty 
shown as standard error. 
 




Table 1:  Primary structure of peptides analyzed in this study with abbreviated names. 
Cationic residues are shown in boldface with mutated residues underlined. 
 
 
Peptide Primary Structure 
Buforin II (21 amino acids)  
Wildtype (BF2) TRSSRAGLQWPVGRVHRLLRK 
Lysine Mutant (BF2K) TKSSKAGLQWPVGKVHKLLKK 
Arginine Mutant (BF2R) TRSSRAGLQWPVGRVHRLLRR 
  
DesHDAP1 (19 amino acids)  
Wildtype (Des1) ARDNKKTRIWPRHLQLAVRN 
Lysine Mutant (Des1K) AKDNKKTKIWPKHLQLAVKN 
Arginine Mutant (Des1R) ARDNRRTRIWPRHLQLAVRN 
  
Parasin (20 amino acids)  
Wildtype (Parasin) KGRGKQGGKVRAKWKTRSS 
Lysine Mutant (ParasinK) KGKGKQGGKVKAKWKTKSS 




Table 2:  Final average peak wavelength of peptide tryptophan emission spectra after 
addition of 3:1 POPC:POPG vesicles. Starred values are significantly different between 
arginine and lysine mutants with p≤0.01.   
 
Peptide Wildtype final peak 
wavelength (nm) 
Arginine mutant final 
peak wavelength (nm) 
Lysine mutant final peak 
wavelength (nm)  
BF2 349.8±0.5 351.0±1 351.8±0.2 
DesHDAP1 354.2±0.6 353.5±0.5* 355.5±0.2* 
Parasin 355.7±0.4 355.8±0.2 355.2±0.6 	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